The arc of biotechnology is one of breakthroughs and struggles, writes Tim Hunt, CEO of the Alliance for Regenerative ...

Q4 2024 Management View Walter Klemp, Chairman and CEO, announced significant progress on the MIRACLE Phase 3 pivotal trial for Annamycin, targeting second-line treatment of relapsed and refractory ...

Supreme Court hearings on GM crops progress, DBT supports GM mustard, BioE3 policy focus, bio-agriculture growth in India.

despite acknowledging Xencor's pipeline progress. The divergence in analyst views underscores the speculative nature of biotechnology investments and the importance of upcoming clinical data in ...

The slow and partial implementation of EU legislation by some member states remains a major obstacle to the development of the EU life sciences and biotechnology sector, according to the latest ...

The MBP research includes quarterly progress reports in lieu of a formal thesis. The final report is modeled after a research article and rivals theses required by other MS in biotechnology programs.

Heltzen expressed excitement for the event, emphasizing the company's progress in advancing sustainable biotechnology through their innovative AI-engineered enzymes, known as exozymes, which aim ...

Compass is a clinical-stage biotechnology company focused on developing ... Compass has made significant progress. The company has strengthened its leadership team, reduced risks for psilocybin ...

Oncolytics (ONCY) reported on progress in 2025 with key regulatory ... Hot Stocks on TipRanks >> Read More on ONCY: Oncolytics Biotech NewsMORE Related Stocks Indices Commodities Currencies ...

Recent clinical data presentations in these two hard-to-treat GI cancers, coupled with strong efficacy signals in breast cancer, demonstrate the potential of pelareorep across very different tumor ...